We are a clinical-stage biopharmaceutical company focused on neuroscience.  

We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive. And it’s what we love to do. 

A key focus of our R&D is to develop first-in-class medicines for people with debilitating neurodegenerative conditions. Our management and technical teams have many years of drug development experience. Prior to coming together they achieved twelve FDA drug approvals in neuroscience and other areas of clinical medicine. Our expertise represents a cross-section of drug development disciplines, including preclinical development, clinical development, medical affairs, regulatory, pharmaceutical development and supply chain management.